vs
Eton Pharmaceuticals, Inc.（ETON）与RBB Bancorp（RBB）财务数据对比。点击上方公司名可切换其他公司
RBB Bancorp的季度营收约是Eton Pharmaceuticals, Inc.的1.5倍（$32.3M vs $21.3M），RBB Bancorp净利率更高（31.5% vs 7.0%，领先24.5%），Eton Pharmaceuticals, Inc.同比增速更快（82.7% vs 12.6%），RBB Bancorp自由现金流更多（$42.6M vs $-11.6M），过去两年Eton Pharmaceuticals, Inc.的营收复合增速更高（63.4% vs 7.0%）
Eton Pharmaceuticals, Inc.是一家专科制药企业，专注于罕见病、儿科用药及医院护理领域创新疗法的研发与商业化，主要面向美国市场，与医疗行业相关方合作，为服务不足的患者群体提供可及的优质治疗方案。
RBB银行控股公司是总部位于美国的金融控股集团，旗下核心主体为皇家商业银行，主要服务亚裔社群、中小微企业、不动产投资者及零售客户，提供商业信贷、储蓄存款、财富管理等多元金融服务，业务覆盖美国沿海核心都会区。
ETON vs RBB — 直观对比
营收规模更大
RBB
是对方的1.5倍
$21.3M
营收增速更快
ETON
高出70.1%
12.6%
净利率更高
RBB
高出24.5%
7.0%
自由现金流更多
RBB
多$54.2M
$-11.6M
两年增速更快
ETON
近两年复合增速
7.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $21.3M | $32.3M |
| 净利润 | $1.5M | $10.2M |
| 毛利率 | 61.6% | — |
| 营业利润率 | 11.6% | 39.5% |
| 净利率 | 7.0% | 31.5% |
| 营收同比 | 82.7% | 12.6% |
| 净利润同比 | 348.0% | 132.1% |
| 每股收益（稀释后） | — | $0.59 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ETONRBB
| Q4 25 | $21.3M | $32.3M | ||
| Q3 25 | $22.5M | $32.6M | ||
| Q2 25 | $18.9M | $35.8M | ||
| Q1 25 | $17.3M | $28.5M | ||
| Q4 24 | $11.6M | $28.7M | ||
| Q3 24 | $10.3M | $30.3M | ||
| Q2 24 | $9.1M | $27.5M | ||
| Q1 24 | $8.0M | $28.2M |
净利润ETONRBB
| Q4 25 | $1.5M | $10.2M | ||
| Q3 25 | $-1.9M | $10.1M | ||
| Q2 25 | $-2.6M | $9.3M | ||
| Q1 25 | $-1.6M | $2.3M | ||
| Q4 24 | $-598.0K | $4.4M | ||
| Q3 24 | $627.0K | $7.0M | ||
| Q2 24 | $-3.0M | $7.2M | ||
| Q1 24 | $-811.0K | $8.0M |
毛利率ETONRBB
| Q4 25 | 61.6% | — | ||
| Q3 25 | 35.0% | — | ||
| Q2 25 | 63.0% | — | ||
| Q1 25 | 57.1% | — | ||
| Q4 24 | 55.6% | — | ||
| Q3 24 | 61.0% | — | ||
| Q2 24 | 62.0% | — | ||
| Q1 24 | 62.9% | — |
营业利润率ETONRBB
| Q4 25 | 11.6% | 39.5% | ||
| Q3 25 | -6.1% | 40.7% | ||
| Q2 25 | -7.8% | 36.1% | ||
| Q1 25 | -2.7% | 11.2% | ||
| Q4 24 | 5.4% | 17.6% | ||
| Q3 24 | 4.9% | 31.6% | ||
| Q2 24 | -32.3% | 35.6% | ||
| Q1 24 | -10.0% | 39.9% |
净利率ETONRBB
| Q4 25 | 7.0% | 31.5% | ||
| Q3 25 | -8.6% | 31.2% | ||
| Q2 25 | -13.7% | 26.1% | ||
| Q1 25 | -9.1% | 8.0% | ||
| Q4 24 | -5.1% | 15.3% | ||
| Q3 24 | 6.1% | 23.1% | ||
| Q2 24 | -33.5% | 26.4% | ||
| Q1 24 | -10.2% | 28.4% |
每股收益（稀释后）ETONRBB
| Q4 25 | — | $0.59 | ||
| Q3 25 | $-0.07 | $0.59 | ||
| Q2 25 | — | $0.52 | ||
| Q1 25 | — | $0.13 | ||
| Q4 24 | — | $0.26 | ||
| Q3 24 | $0.02 | $0.39 | ||
| Q2 24 | $-0.12 | $0.39 | ||
| Q1 24 | $-0.03 | $0.43 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $25.9M | $212.3M |
| 总债务越低越好 | — | $119.9M |
| 股东权益账面价值 | $26.2M | $523.4M |
| 总资产 | $92.1M | $4.2B |
| 负债/权益比越低杠杆越低 | — | 0.23× |
8季度趋势，按日历期对齐
现金及短期投资ETONRBB
| Q4 25 | $25.9M | $212.3M | ||
| Q3 25 | $37.1M | $234.9M | ||
| Q2 25 | $25.4M | $191.9M | ||
| Q1 25 | $17.4M | $238.8M | ||
| Q4 24 | $14.9M | $257.7M | ||
| Q3 24 | $20.3M | $349.4M | ||
| Q2 24 | $17.7M | $252.8M | ||
| Q1 24 | $16.7M | — |
总债务ETONRBB
| Q4 25 | — | $119.9M | ||
| Q3 25 | — | $119.8M | ||
| Q2 25 | — | $119.7M | ||
| Q1 25 | $30.0M | $119.6M | ||
| Q4 24 | $29.8M | $119.5M | ||
| Q3 24 | — | $119.4M | ||
| Q2 24 | — | $119.3M | ||
| Q1 24 | — | $119.2M |
股东权益ETONRBB
| Q4 25 | $26.2M | $523.4M | ||
| Q3 25 | $23.1M | $514.3M | ||
| Q2 25 | $24.0M | $517.7M | ||
| Q1 25 | $24.4M | $510.3M | ||
| Q4 24 | $24.4M | $507.9M | ||
| Q3 24 | $16.0M | $509.7M | ||
| Q2 24 | $13.5M | $511.3M | ||
| Q1 24 | $15.5M | $514.0M |
总资产ETONRBB
| Q4 25 | $92.1M | $4.2B | ||
| Q3 25 | $104.5M | $4.2B | ||
| Q2 25 | $101.7M | $4.1B | ||
| Q1 25 | $84.0M | $4.0B | ||
| Q4 24 | $76.1M | $4.0B | ||
| Q3 24 | $35.8M | $4.0B | ||
| Q2 24 | $31.8M | $3.9B | ||
| Q1 24 | $30.8M | $3.9B |
负债/权益比ETONRBB
| Q4 25 | — | 0.23× | ||
| Q3 25 | — | 0.23× | ||
| Q2 25 | — | 0.23× | ||
| Q1 25 | 1.23× | 0.23× | ||
| Q4 24 | 1.22× | 0.24× | ||
| Q3 24 | — | 0.23× | ||
| Q2 24 | — | 0.23× | ||
| Q1 24 | — | 0.23× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-11.6M | $43.4M |
| 自由现金流经营现金流 - 资本支出 | $-11.6M | $42.6M |
| 自由现金流率自由现金流/营收 | -54.5% | 131.8% |
| 资本支出强度资本支出/营收 | 0.2% | 2.5% |
| 现金转化率经营现金流/净利润 | -7.79× | 4.26× |
| 过去12个月自由现金流最近4个季度 | — | $73.5M |
8季度趋势，按日历期对齐
经营现金流ETONRBB
| Q4 25 | $-11.6M | $43.4M | ||
| Q3 25 | $12.0M | $2.1M | ||
| Q2 25 | $8.0M | $21.7M | ||
| Q1 25 | $2.1M | $7.8M | ||
| Q4 24 | $-765.0K | $58.5M | ||
| Q3 24 | $3.0M | $24.5M | ||
| Q2 24 | $1.3M | $11.7M | ||
| Q1 24 | $-2.5M | $4.8M |
自由现金流ETONRBB
| Q4 25 | $-11.6M | $42.6M | ||
| Q3 25 | $11.7M | $1.8M | ||
| Q2 25 | — | $21.6M | ||
| Q1 25 | — | $7.6M | ||
| Q4 24 | $-777.0K | $57.7M | ||
| Q3 24 | — | $24.2M | ||
| Q2 24 | — | $11.5M | ||
| Q1 24 | $-2.5M | $4.7M |
自由现金流率ETONRBB
| Q4 25 | -54.5% | 131.8% | ||
| Q3 25 | 52.3% | 5.4% | ||
| Q2 25 | — | 60.2% | ||
| Q1 25 | — | 26.7% | ||
| Q4 24 | -6.7% | 201.0% | ||
| Q3 24 | — | 80.0% | ||
| Q2 24 | — | 42.0% | ||
| Q1 24 | -31.2% | 16.6% |
资本支出强度ETONRBB
| Q4 25 | 0.2% | 2.5% | ||
| Q3 25 | 1.3% | 1.1% | ||
| Q2 25 | 0.0% | 0.3% | ||
| Q1 25 | 0.0% | 0.6% | ||
| Q4 24 | 0.1% | 2.7% | ||
| Q3 24 | 0.0% | 0.8% | ||
| Q2 24 | 0.0% | 0.5% | ||
| Q1 24 | 0.2% | 0.5% |
现金转化率ETONRBB
| Q4 25 | -7.79× | 4.26× | ||
| Q3 25 | — | 0.21× | ||
| Q2 25 | — | 2.32× | ||
| Q1 25 | — | 3.39× | ||
| Q4 24 | — | 13.34× | ||
| Q3 24 | 4.71× | 3.50× | ||
| Q2 24 | — | 1.61× | ||
| Q1 24 | — | 0.60× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
